These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9501463)

  • 1. Studies on nonpeptide angiotensin II receptor antagonists. II. Synthesis and biological evaluation of 5H-pyrazolo[1,5-b][1,2,4]triazole derivatives with a C-linked oxygen functional group at the 6-position.
    Okazaki T; Suga A; Watanabe T; Kikuchi K; Kurihara H; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 Feb; 46(2):287-93. PubMed ID: 9501463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on nonpeptide angiotensin II receptor antagonists. I. Synthesis and biological evaluation of pyrazolo[1,5-b][1,2,4]triazole derivatives with alkyl substituents.
    Okazaki T; Suga A; Watanabe T; Kikuchi K; Kurihara H; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa U
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):69-78. PubMed ID: 9468638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
    Okazaki T; Watanabe T; Kikuchi K; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):973-81. PubMed ID: 9658576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.
    Ashton WT; Cantone CL; Chang LL; Hutchins SM; Strelitz RA; MacCoss M; Chang RS; Lotti VJ; Faust KA; Chen TB
    J Med Chem; 1993 Mar; 36(5):591-609. PubMed ID: 8496939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids.
    Kubo K; Kohara Y; Imamiya E; Sugiura Y; Inada Y; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jul; 36(15):2182-95. PubMed ID: 8340921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on nonpeptide angiotensin II receptor antagonists. III. Synthesis and biological evaluation of 5-alkylidene-3,5-dihydro-4H-imidazol-4-one derivatives.
    Okazaki T; Kikuchi K; Watanabe T; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 May; 46(5):777-81. PubMed ID: 9621411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
    Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
    Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
    Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.
    Ashton WT; Hutchins SM; Greenlee WJ; Doss GA; Chang RS; Lotti VJ; Faust KA; Chen TB; Zingaro GJ; Kivlighn SD
    J Med Chem; 1993 Nov; 36(23):3595-605. PubMed ID: 8246227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996).
    Sircar I; Hodges JC; Quin J; Bunker AM; Winters RT; Edmunds JJ; Kostlan CR; Connolly C; Kesten SJ; Hamby JM
    J Med Chem; 1993 Aug; 36(16):2253-65. PubMed ID: 8360871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists.
    Huang HC; Reitz DB; Chamberlain TS; Olins GM; Corpus VM; McMahon EG; Palomo MA; Koepke JP; Smits GJ; McGraw DE
    J Med Chem; 1993 Jul; 36(15):2172-81. PubMed ID: 8340920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist.
    Mizuno M; Sada T; Ikeda M; Fukuda N; Miyamoto M; Yanagisawa H; Koike H
    Eur J Pharmacol; 1995 Oct; 285(2):181-8. PubMed ID: 8566137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids.
    Kubo K; Kohara Y; Yoshimura Y; Inada Y; Shibouta Y; Furukawa Y; Kato T; Nishikawa K; Naka T
    J Med Chem; 1993 Aug; 36(16):2343-9. PubMed ID: 8360879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacological characterization of a new selective angiotensin AT1 receptor antagonist, UR-7280.
    De Arriba AF; Gómez-Casajús LA; Cavalcanti F; Almansa C; García-Rafanell J; Forn J
    Eur J Pharmacol; 1996 Dec; 318(2-3):341-7. PubMed ID: 9016924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs.
    Shibasaki M; Fujimori A; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
    Eur J Pharmacol; 1997 Sep; 335(2-3):175-84. PubMed ID: 9369371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
    Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A
    Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones.
    Chang LL; Ashton WT; Flanagan KL; Strelitz RA; MacCoss M; Greenlee WJ; Chang RS; Lotti VJ; Faust KA; Chen TB
    J Med Chem; 1993 Aug; 36(17):2558-68. PubMed ID: 8355255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M; Provost D; Versigny A; Cloarec A
    Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells.
    Flesch M; Ko Y; Seul C; Düsing R; Feltkamp H; Vetter H; Sachinidis A
    Eur J Pharmacol; 1995 Apr; 289(2):399-402. PubMed ID: 7621917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.